- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neuland Laboratories Ltd (NEUL)
Neuland Laboratories Ltd stock price live, this page displays NSE NEUL stock exchange data. View the NEUL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neuland Laboratories Ltd real time stock price chart below.
What Is the Neuland Laboratories Ltd Stock Price Today?
The Neuland Laboratories Ltd stock price today is 23,330.00.
What Is the Stock Symbol for Neuland Laboratories Ltd?
The stock symbol for Neuland Laboratories Ltd is "NEUL."
What Stock Exchange Does Neuland Laboratories Ltd Trade On?
Neuland Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Neuland Laboratories Ltd a Good Stock to Buy?
Determining whether Neuland Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NEUL quote. (ISIN: INE794A01010)
What Is the Neuland Laboratories Ltd Stock Price Today?
The Neuland Laboratories Ltd stock price today is 23,330.00.
What Is the Stock Symbol for Neuland Laboratories Ltd?
The stock symbol for Neuland Laboratories Ltd is "NEUL."
What Stock Exchange Does Neuland Laboratories Ltd Trade On?
Neuland Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Neuland Laboratories Ltd a Good Stock to Buy?
Determining whether Neuland Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NEUL quote. (ISIN: INE794A01010)
23,330.00
+123.00(+0.53%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23,030.00
23,650.00
52 wk Range
11,500.00
23,650.00
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23,030.0023,650.00
52 wk Range
11,500.0023,650.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.15%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.15%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NEUL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Neuland Laboratories Ltd Earnings Call Summary for Q1/2027
- Neuland Labs Q1 FY2027 total income surged 116.3% YoY to INR 650.1 crores; profit after tax jumped over 10-fold to INR 147.4 crores.
- EBITDA margin expanded to 35.5%, exceeding long-term 25%+ target; working capital days improved sharply to 84 from 137 at FY2026 end.
- Management expects FY2027 and FY2028 growth around 20%, with one to two additional commercializations anticipated in current fiscal year.
- Peptide Module One to be commissioned within a month with full utilization expected in FY2027; Module Two activation possible if demand warrants.
- Strategic collaboration with Gland Pharma for sterile APIs launched; shares rose 3.54% to $19,956, near 52-week high of $20,099.
Last Updated: 08/05/2026, 09:22 PM
Read Full TranscriptEarnings
Latest Release
Aug 05, 2026
EPS / Forecast
115.00 / 60.52
Revenue / Forecast
6.42B / 5.39B
Compare NEUL to Peers and Sector
Metrics to compare | NEUL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNEULPeersSector | |
|---|---|---|---|---|
P/E Ratio | 59.9x | 32.7x | −0.4x | |
PEG Ratio | 0.33 | 0.70 | 0.00 | |
Price/Book | 15.9x | 4.7x | 2.6x | |
Price / LTM Sales | 12.6x | 3.7x | 3.1x | |
Upside (Analyst Target) | 3.9% | 5.1% | 48.4% | |
Fair Value Upside | Unlock | −1.9% | 6.5% | Unlock |
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Neuland Laboratories (NEUL) Stock Price Today?
The Neuland Laboratories stock price today is 23,330.00 INR.
What Stock Exchange Does Neuland Laboratories Trade On?
Neuland Laboratories is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Neuland Laboratories?
The stock symbol for Neuland Laboratories is "NEUL."
Does Neuland Laboratories Pay Dividends? What’s The Current Dividend Yield?
The Neuland Laboratories dividend yield is 0.15%.
What Is the Neuland Laboratories Market Cap?
As of today, Neuland Laboratories market cap is 298.99B INR.
What Is Neuland Laboratories's Earnings Per Share (TTM)?
The Neuland Laboratories EPS (TTM) is 388.01.
When Is the Next Neuland Laboratories Earnings Date?
Neuland Laboratories will release its next earnings report on Nov 10, 2026.
From a Technical Analysis Perspective, Is NEUL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Neuland Laboratories Stock Split?
Neuland Laboratories has split 2 times.
How Many Employees Does Neuland Laboratories Have?
Neuland Laboratories has 2183 employees.
What is the current trading status of Neuland Laboratories (NEUL)?
As of Aug 14, 2026, Neuland Laboratories (NEUL) is trading at a price of 23,330.00 INR, with a previous close of 23,207.00 INR. The stock has fluctuated within a day range of 23,030.00 INR to 23,650.00 INR, while its 52-week range spans from 11,500.00 INR to 23,650.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.